Remove Article Remove Clinical Trials Remove History
article thumbnail

Final Phase of MDMA Clinical Trials Shows Drug Is 90% Effective at Treating PTSD

SpeedWeed

A first-of-its-kind Phase 3 clinical trial has found that MDMA-assisted therapy provided meaningful relief from PTSD symptoms in nearly 90 percent of study participants. The subjects had been experiencing PTSD symptoms for an average of 14 years, and 84 percent had a history of developmental trauma. View original article.

article thumbnail

Dr. Andrew Weil on Cannabis and Integrative Medicine

Project CBD

NM: Please tell us about the history of cannabis use in folk medicine. Dr. Weil: Cannabis has a long history of use in folk medicine throughout the world. With that little time, you can’t really take a full history. It has as far back as you go in history. I think that’s going to happen very soon.

Medicine 306
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Article: Intellectual Property Due Diligence in Psychedelics

Cannabis Law Report

Unlike novel chemical compounds that are synthetically produced in the pharmaceutical industry through drug development programs, psychedelic compounds have a long and established history. As we see more data emerge from clinical trials, we are likely to see patent applications covering stability, pharmacokinetic, and pharmacodynamic data.

article thumbnail

Researchers Concerned About Whitewashing of Psychedelic-Assisted Mental Health Research

Cannabis Law Report

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.

article thumbnail

New Study From UNM Shows Full Spectrum Hemp Oil Effective in Treating Chronic Neuropathic Pain

MedicalJane

Animal studies are not only valuable, they can also be superior to clinical trials in some cases because they can circumvent human biases and expectancy effects, or perceptual and cognitive reactions to participation in cannabis-based experiments. The Hemp Farming Act of 2018.

Oil 100
article thumbnail

Study: CBD “Promising” Therapy for Cocaine Addiction

CannaMD

After the removal of duplicates, the titles and abstracts of 52 articles were analyzed, 21 of which were considered potentially eligible. Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., mice/rats). Hepatic protection.

Therapy 98
article thumbnail

And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity

Cannabis Law Report

This landmark approval is unique in that ketamine is well known to have hallucinogenic properties, as well as a long history as a party drug. So, there’s no overarching reason to think psychedelics can’t be handled in the same manner, especially if a drug successfully completes a rigorous clinical trial program.